Stay updated on Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page
- Check4 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check17 days agoChange DetectedThe study page now displays a 403 Forbidden error, blocking access to the record and showing the site's standard error layout.SummaryDifference17%

- Check24 days agoChange DetectedThe page's revision label was updated from v3.6.6 to v3.7.0, indicating a backend/software update to the page rendering.SummaryDifference0.0%

- Check39 days agoChange DetectedThe page’s revision label was updated from v3.6.5 to v3.6.6, signaling a new version of the page was published. This represents a version-tracking update rather than a substantive change to the displayed content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe study identifiers now include '2017 ( U.S. NIH Grant/Contract )', alongside the existing ANB019-003 and the EudraCT number (2017-004022-15).SummaryDifference0.0%

- Check60 days agoChange DetectedA new revision is applied (v3.6.5), replacing the previous v3.6.4 revision. This indicates a backend update to the page's versioning or content management, likely addressing maintenance or internal improvements rather than visible content changes.SummaryDifference0.0%

Stay in the know with updates to Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.